2483829-92-9
2483829-92-9
Chemical Structure
Hexanoylglycine-13C2,15N
- CAS No.: 2483829-92-9
- Formula:C613C2H1515NO3
- Molecular Weight:176.19
InChIKey: UPCKIPHSXMXJOX-LGJOFTTCSA-N
SMILES: O[13C]([13CH2][15NH]C(CCCCC)=O)=O
Biological Activity: Hexanoylglycine-13C2,15N is the 13C- and 15N-labeled Hexanoylglycine (HY-113150). Hexanoylglycine is an endogenous metabolite present in Urine that can be used for the research of Ethylmalonic Encephalopathy[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Hexanoylglycine-13C2,15N | Hexanoylglycine-13C2,15N is the 13C- and 15N-labeled Hexanoylglycine (HY-113150). Hexanoylglycine is an endogenous metabolite present in Urine that can be used for the research of Ethylmalonic Encephalopathy. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Hexanoylglycine (Standard) | ≥98% | Hexanoylglycine (Standard) is the analytical standard of Hexanoylglycine. This product is intended for research and analytical applications. Hexanoylglycine is an endogenous metabolite present in Urine that can be used for the research of Ethylmalonic Encephalopathy. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Hexanoylglycine-d2 | 98.0% | Hexanoylglycine-d2 is the deuterium labeled Hexanoylglycine. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Hexanoylglycine-d11 | 99.94% | Hexanoylglycine-d11 is the deuterium labeled Hexanoylglycine. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Hexanoylglycine | 99.67% | Hexanoylglycine is an endogenous metabolite present in Urine that can be used for the research of Ethylmalonic Encephalopathy. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Nowaczyk MJ, et al. Ethylmalonic and methylsuccinic aciduria in ethylmalonic encephalopathy arise from abnormal isoleucine metabolism. Metabolism. 1998 Jul;47(7):836-9. [Content Brief]
- [2]. Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39(35):5709-5720. [Content Brief]
